These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23581062)

  • 1. Clinical trials.
    Keill R
    Bull Am Coll Surg; 2003 May; 88(5):43. PubMed ID: 23581062
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib: as adjuvant therapy for gastrointestinal stromal tumor†: profile report.
    Sanford M; Scott LJ
    BioDrugs; 2011 Jun; 25(3):191-2. PubMed ID: 21627342
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant imatinib for GIST: the pie is shrinking.
    Balachandran VP; DeMatteo RP
    Ann Surg Oncol; 2014 Oct; 21(11):3365-6. PubMed ID: 25120253
    [No Abstract]   [Full Text] [Related]  

  • 4. Imatinib mesylate as therapy for gastrointestinal stromal tumor.
    Peshwe HB; Chatni S; Basu S
    Indian J Gastroenterol; 2005; 24(4):188. PubMed ID: 16204927
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S; Jia J; Pan YL; Tao DY; Lu HS
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical aspects of managing gastrointestinal stromal tumors.
    Sleijfer S; Seynaeve C; Wiemer E; Verweij J
    Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S18-23. PubMed ID: 17101064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
    Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
    De Giorgi U
    Future Oncol; 2013 Nov; 9(11):1675-7. PubMed ID: 23862700
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor.
    Shah JN; Sun W; Seethala RR; Livolsi VA; Fry RD; Ginsberg GG
    Gastrointest Endosc; 2005 Apr; 61(4):625-7. PubMed ID: 15812427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Curative resection of an extra-gastrointestinal stromal tumor locally advanced and fistulizing in the small intestine after treatment with imatinib: report of a case].
    Bouassria A; Mouaqit O; Benjelloun E; Elbouhaddouti H; Ousadden A; Mazaz K; Taleb KA
    Pan Afr Med J; 2014; 17():247. PubMed ID: 25309647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
    Abhyankar SA; Nair N
    Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851
    [No Abstract]   [Full Text] [Related]  

  • 12. Sunitinib for imatinib-resistant GIST.
    Joensuu H
    Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastrointestinal stromal tumor (GIST)--tyrosine kinase inhibitors].
    Nishida T; Yoshidome K; Tori M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():452-6. PubMed ID: 23513883
    [No Abstract]   [Full Text] [Related]  

  • 14. Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib.
    Armbrust T; Sobotta M; Ramadori G
    Ann Oncol; 2007 Jun; 18(6):1123-5. PubMed ID: 17586757
    [No Abstract]   [Full Text] [Related]  

  • 15. Current management of GISTs.
    Blanke C
    Clin Adv Hematol Oncol; 2010 May; 8(5):334. PubMed ID: 20551892
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
    Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
    Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib].
    Bouché O; Lagarde S; Guillou PJ; Ramaholimihaso F; Lubrano D; Diébold MD; Delattre JF; Nguyen TD; Cadiot G; Thiéfin G
    Gastroenterol Clin Biol; 2006 Apr; 30(4):636-7. PubMed ID: 16733396
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow up of patient with totally resected gastric stromal tumor.
    Tzilves D; Moschos J; Paikos D; Katsos I; Tarpagos A
    Indian J Gastroenterol; 2006; 25(1):47-8; author reply 48. PubMed ID: 16567904
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo imatinib sensitivity in a patient with GI stromal tumor bearing a PDGFRA deletion DIM842-844.
    Fanta PT; Sicklick JK; Betz BL; Peterson MR
    J Clin Oncol; 2015 Mar; 33(8):e41-4. PubMed ID: 24638008
    [No Abstract]   [Full Text] [Related]  

  • 20. First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.
    Salazar M; Barata A; André S; Venâncio J; Francisco I; Cravo M; Nobre-Leitão C
    Gut; 2006 Apr; 55(4):585-6. PubMed ID: 16531543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.